Menu Menu Menu
Nice Insight Research
Content Menu
Menu Menu Menu
To Top

Search By Topic

Supply Chain

78 Articles available
Distribution Agreement

Orsini Healthcare Specialty Pharmacy Selected by Alnylam Pharmaceuticals to Distribute ONPATTRO™ (patisiran)

PR-M09-18-NI-019
Logistics

LATAM Cargo Opens Pharma Hub in Denmark

PR-M09-18-NI-073
Marketing Approval

Novadoz Receives Marketing Approval for Generic Versions of Rosuvastatin, Capecitabine, & Moxifloxacin

PR-M08-18-NI-097
Supply Chain

Marken Offers First Hybrid Service from Brazil to USA

PR-M08-18-NI-124
Supply Chain

Building a Robust Supply Chain with Dependable Quality Primary Suppliers

PAO-M07-18-CL-001
Clinical Trials

Marken Announces Plans To Add Nursing Services To Home-Based Trials

PR-M04-18-NI-69
Supply Chain

Intertek launches Inlight™ Advantage to accelerate the compliance onboarding process at every level of the supply chain 

PR-M03-18-NI-110
Supply Chain

Overcoming Challenges in the Complex Market for Clinical Trials and Clinical Logistics

PAP-Q1-18-CL-010
Fill/Finish

Getting to the Finish Line

PAP-Q1-18-NI-004
Expanded Capacity

Catalent Completes $4.6 Million Expansion at Singapore Clinical Supply Facility

PR-M03-18-NI-008
Clinical Trials

The UPS Store, Marken Team Up For Drop-Off Service For Clinical Trial Samples In U.S.

PR-M03-18-NI-007
Appointment

Marken Appoints New Vice President, Global Quality Assurance

PR-M02-18-NI-81
Vaccine

First vaccine carrier approved by World Health Organization to prevent vaccine freezing during transport commercially available

PR-M02-18-NI-041
Market Expansion

Marken Accelerates Its Reach And Growth In Clinical Trial Logistics

PR-M02-18-NI-031
Strategic Partnership

WuXi Partners with Swedish Firm to Establish New Contract Manufacturer

PAO-M01-18-NI-043
Opening

Marken Opens New Location In Stuttgart, Germany

PR-M01-18-NI-083
Merger

CMC Biologics Becomes AGC Biologics

PAO-M01-18-NI-032
Expanded Capacity

Marken Opens New Kit Building Facility In Shanghai

PR-M01-18-NI-057
Partnership

Boehringer Ingelheim and Adimab Partner on Antibodies

PAO-M01-18-NI-030
CDMO

Pulmonx Submits Premarket Approval (PMA) Application to U.S. FDA for Zephyr Endobronchial Valve as Treatment for Emphysema

PR-M01-18-NI-039
Joint Venture

WuXi AppTec Group and Mayo Clinic Form Joint Venture to Deliver Clinical Diagnostic Services

PR-M01-18-NI-027
Launch

Former Receptos Executives Launch Gossamer Bio, Inc., a New Biopharma Company Focused on Discovering and Developing a Pipeline of Novel and Differentiated Drug Candidates

PR-M01-18-NI-025
Big Data

Regeneron Forms Consortium of Leading Life Sciences Companies to Accelerate Largest Widely-Available 'Big Data' Human Sequencing Resource with UK Biobank

PR-M01-18-NI-020
Transition

Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)

PR-M01-18-NI-017
Breakthrough Therapy

AbbVie's Upadacitinib Granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Atopic Dermatitis

PR-M01-18-NI-018
CDMO

Takeda and Denali Therapeutics Collaborate to Develop and Commercialize Therapies for Neurodegenerative Diseases

PR-M01-18-NI-015
Drug Development

Promacta Gets Breakthrough Therapy Designation

PAO-M01-18-NI-012
Drug Discovery

Defense Department Commits $16 Million to Fight Bacterial Bioweapons

PAO-M01-18-NI-010
Drug Development

Array BioPharma Forms New Subsidiary Yarra Therapeutics

PAO-M01-18-NI-007
Cell and Gene Therapy

FDA Approves Gene Therapy

PAO-M01-18-NI-005
FDA Guidance

FDA Received Numerous Comments on Its Draft Guidance for Evaluating Biosimilarity

PAO-M01-18-NI-004
Acquisition

Gilead’s new Kite Subsidiary To Buy CAR-T Cell Therapy Company Cell Design Labs

PAO-M01-18-NI-001
Research

Tumor Killing Combo Wins Third U.S. Patent

PAO-M12-17-NI-033
Added Capacity

World’s Largest Biologics Plant Gets EMA Nod

PAO-M12-17-NI-029
Innovation

Renova Therapeutics' Gene Transfer Tech Enters the Fast Lane

PAO-M12-17-NI-028
Clinical Trials

Novo Nordisk Bags FDA Approval for New Diabetes Treatment

PAO-M12-17-NI-024
FDA

New FDA Draft Guidance Intended to Accelerate Development of Drugs for Rare Pediatric Diseases

PAO-M12-17-NI-023
API Manufacturing

BioVectra and Keryx Biopharmaceuticals Enter Agreement for Ferric Citrate Production Expansion

PR-M12-17-NI-013
Acquisition

Pharmaterials Acquired by Quotient Sciences

PAO-M11-17-NI-051
Innovation

Single-Pill, HIV-1 Combination Therapy Approved

PAO-M11-17-NI-050
Discovery

Boehringer Ingelheim and HitGen Enter Drug Discovery Collaboration

PAO-M11-17-NI-049
Investment

Bellwyck and Faller Establish Joint Venture in Germany

PR-M11-17-NI-015
Clinical Trials

Managing the Complexities of Outbound Clinical Drug Distribution

PAP-Q4-17-CL-001
Automation

Pharma’s Automation Index on the Rise

PAP-Q4-17-FA-003
Supply Chain

IEEE Releases First Detailed Study of Blockchain Technology in Pharma

PAO-M10-17-NI-027
Logistics

Marken Delivering New Hybrid Service

PR-M09-17-NI-002
Clinical Logistics

Managing the Complexity of Global Clinical Logistics for Next-Generation Personalized Medicines

PAP-Q3-17-CL-007
Design Logic

Marken: Stronger Than Ever

PAP-Q3-17-DL-001
CDMO

The CDMO and the International Supply Chain: How Global and Local Relationships are Guiding Sponsors and Providers

PAP-Q3-17-FA-001
FDA

Pharma Manufacturers Now Have FDA Draft Guidance on Securing the Drug Supply Chain

PAO-M09-17-NI-003
CDMO

Benefitting from Embedded Quality for End-to-End Success

Gwenael Servant, Managing Director, Servier CDMO

PTV-M01-17-NS-010
Supply Chain

Increasing Productivity and Profitability

Pamela J. Roach, CEO, Breakthrough Marketing Technology LLC

PTV-M01-17-NS-006
Supply Chain

Direct to Patient Logistics and Technology

Paddy Hanlon, Vice President, Commercial Operations East Coast & Canada, Marken

PTV-M01-17-NS-003
Supply Chain

An Inside Look: Strategy at SGS

Fadia Alkhalil-Gadar, VP of Global Business Development, SGS

PTV-M11-16-AP-020
Supply Chain

Keeping the Chain Going

PAP-Q1-17-FA-007
CDMO

2017 Top 5 Industry Leader

PAP-Q1-17-IL-001
Equipment

Q: How is the Need to Provide Local Drug-Product Supply in Multiple Regions Around the World Impacting Pharmaceutical Manufacturing Facility and Equipment Design?

PAP-Q1-17-RT-002
API

Q: What will be the Impact of the Requirements that Drug Manufacturers Gain a Similar Level of Supply Chain Understanding for Excipients as they Must Have for APIs?

PAP-Q1-17-RT-005
Supply Chain

Dissolving Boundaries in Worldwide Clinical Trial Logistics for Biological Samples and New Therapies

PAP-Q1-17-CL-011
CDMO

Raw Material Supply: Many Issues to Manage

POP-M10-16-NI-001
Biologics

INNOVATION: Creating Solutions for Healthcare’s Ambitious Agenda

PAP-Q04-16-FA-001
CDMO

This Just In

PAP-Q04-16-JI-001
CDMO

Supply Chain Management and the Importance of Security of Supply

PAP-Q04-16-CL-002
Supply Chain

Nice Insight’s Content Community Goes Live Online | An Industry Portal for Data, Knowledge, Thought Leadership and Opinion

PAP-Q04-16-ND-001
Supply Chain

Perspectives on Product Pricing Strategy and Practice

PAP-Q04-16-NC-001
CDMO

Equipment Redeployment’s Strategic Role

PAP-Q04-16-CL-005
CDMO

Rx-360: An Industry Group Like No Other

PAP-Q04-16-CL-007
CDMO

Delivering on Unfulfilled Promises – Building a CDMO

PAP-Q03-16-CL-006
CDMO

Evolving Strategic Partnership Models

PAP-Q03-16-CL-007
Excipients

What Are the Latest Guidelines for Excipients?

POP-M07-16-NI-001
Supply Chain

Strong Growth for CRO Market; Tox Testing Poses Challenges

SCP-M07-16-NI-001
Equipment

2016 Pharmaceutical Equipment Buying Trends

PMP-M08-16-NI-002
Supply Chain

Clinical Logistics – Meeting the 21st Century Cures Challenge

PAP-Q1-16-CL-003
API

Challenges Facing Pharmaceutical Excipients

APR-M05-15-NI-001
API

Improving Global Supply Chain Security in the Pharmaceutical Industry

FPP-M04-15-NI-001
Supply Chain

Strategic Supply & Marketing Agreements as Complementary Alternative to Classic Contract Manufacturing

LSL-M11-14-NI-001
Supply Chain

As Outsourcing Relationships Evolve, Vaccine Production Will Continue to Shift to CMOs

LSL-M05-14-NI-002
Supply Chain

Is a CMO With a Global Supply Chain Always the Best Option?

LSL-M11-11-NI-001
×